Free Trial
NASDAQ:FONR

FONAR (FONR) Stock Price, News & Analysis

$18.53
+0.04 (+0.22%)
(As of 07/26/2024 ET)
Today's Range
$18.32
$18.53
50-Day Range
$14.39
$18.53
52-Week Range
$12.13
$24.05
Volume
5,876 shs
Average Volume
19,819 shs
Market Capitalization
$117.29 million
P/E Ratio
11.88
Dividend Yield
N/A
Price Target
N/A
FONR stock logo

About FONAR Stock (NASDAQ:FONR)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

FONR Stock Price History

FONR Stock News Headlines

FONAR (NASDAQ:FONR) Rating Lowered to Buy at StockNews.com
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Fonar Corp.
Fonar: Fiscal Q2 Earnings Snapshot
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Fonar Corp FONR
2024 Strategies: Buy or Hold for 3 Medical Stocks?
Holiday Outlook: 3 Medical Stocks to Consider Buying
See More Headlines
Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/26/2024
Next Earnings (Estimated)
9/26/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:FONR
Employees
480
Year Founded
N/A

Profitability

Net Income
$9.38 million
Pretax Margin
19.70%

Debt

Sales & Book Value

Annual Sales
$98.64 million
Cash Flow
$2.79 per share
Book Value
$23.07 per share

Miscellaneous

Free Float
6,191,000
Market Cap
$117.29 million
Optionable
Not Optionable
Beta
1.19
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

FONR Stock Analysis - Frequently Asked Questions

How have FONR shares performed this year?

FONAR's stock was trading at $19.56 at the start of the year. Since then, FONR shares have decreased by 5.3% and is now trading at $18.53.
View the best growth stocks for 2024 here
.

How were FONAR's earnings last quarter?

FONAR Co. (NASDAQ:FONR) released its quarterly earnings results on Wednesday, May, 15th. The medical equipment provider reported $0.27 earnings per share for the quarter. The medical equipment provider had revenue of $25.72 million for the quarter. FONAR had a net margin of 10.66% and a trailing twelve-month return on equity of 7.50%.

Who are FONAR's major shareholders?

FONAR's top institutional shareholders include Linden Thomas Advisory Services LLC (0.34%). Insiders that own company stock include Luciano B Bonanni and Timothy Raymond Damadian.
View institutional ownership trends
.

How do I buy shares of FONAR?

Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of FONAR own?

Based on aggregate information from My MarketBeat watchlists, some other companies that FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC) and Incyte (INCY).

This page (NASDAQ:FONR) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners